Eli Lilly and Co (TSX:LLY) Shiller PE Ratio: (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSX:LLY Eli Lilly and Co TSX:LLY
85 GF Score
Price C$41.12
GF Value C$55.89
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Eli Lilly and Co Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Eli Lilly and Co  (TSX:LLY) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Eli Lilly and Co Shiller PE Ratio Related Terms


Eli Lilly and Co Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Eli Lilly and Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co Shiller PE Ratio Chart

Eli Lilly and Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 134.39 141.68 137.12

Eli Lilly and Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 119.75 107.04 137.61 104.40 123.82

TSX:LLY vs JNJ, ABBV, MRK: Shiller PE Ratio Comparison

For the Drug Manufacturers - General subindustry, Eli Lilly and Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Eli Lilly and Co Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Eli Lilly and Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Eli Lilly and Co's Shiller PE Ratio falls into.


TSX:LLY
85GF Score
Eli Lilly and Co TSX:LLY
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eli Lilly and Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Eli Lilly and Co's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Eli Lilly and Co's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=0.2998/333.9520*333.9520
=0.300

Current CPI (Jun. 2026) = 333.9520.

Eli Lilly and Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 0.026 241.428 0.036
201612 0.026 241.432 0.035
201703 -0.004 243.801 -0.005
201706 0.035 244.955 0.047
201709 0.018 246.819 0.024
201712 -0.052 246.524 -0.071
201803 0.038 249.554 0.051
201806 -0.008 251.989 -0.010
201809 0.038 252.439 0.050
201812 0.038 251.233 0.051
201903 0.021 254.202 0.027
201906 0.053 256.143 0.069
201909 0.049 256.759 0.064
201912 0.059 256.974 0.077
202003 0.059 258.115 0.076
202006 0.059 257.797 0.076
202009 0.048 260.280 0.062
202012 0.082 260.474 0.106
202103 0.051 264.877 0.065
202106 0.051 271.696 0.063
202109 0.042 274.310 0.051
202112 0.065 278.802 0.078
202203 0.073 287.504 0.084
202206 0.037 296.311 0.041
202209 0.057 296.808 0.064
202212 0.076 296.797 0.085
202303 0.055 301.836 0.061
202306 0.072 305.109 0.078
202309 -0.002 307.789 -0.002
202312 0.086 306.746 0.093
202403 0.091 312.332 0.098
202406 0.123 314.175 0.130
202409 0.040 315.301 0.042
202412 0.178 315.605 0.188
202503 0.120 319.799 0.125
202506 0.238 322.561 0.246
202509 0.233 324.800 0.240
202512 0.267 324.054 0.275
202603 0.309 330.213 0.312
202606 0.300 333.952 0.300

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Eli Lilly and Co (TSX:LLY) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of C$41.12 is trading 26.4% below its estimated GF Value™ of C$55.89. GuruFocus considers Eli Lilly and Co to be Modestly Undervalued.

Key valuation signals for TSX:LLY:

  • Shiller PE Ratio:
  • GF Value™: C$55.89 vs. price of C$41.12 (26.4% below fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the TSX:LLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
85GF Score

Get the complete analysis for TSX:LLY

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$41.12
Price
C$55.89
GF Value